JS BIOFUTURE INVEST ApS: Financial statements 2022
CVR: 31080983
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
JS BIOFUTURE INVEST ApS (CVR 31080983) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,564 and a net result of DKK -5,118 compared with DKK -44,513 the year before. Equity in the 2022 report amounted to DKK 247,192. The solvency ratio was 32.4%.
- Gross Profit
- DKK -13,564
- Profit/Loss
- DKK -5,118
- Equity
- DKK 247,192
- Total Assets
- DKK 761,960
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -14K | -5K | 247K | 0 |
| 2021 | - | -66K | -45K | 252K | - |
| 2020 | - | -17K | 120K | 297K | - |
| 2019 | - | -6K | 39K | 52K | - |
| 2018 | - | -4K | -13K | 13K | - |
Official annual report
Keep an eye on JS BIOFUTURE INVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
JS BIOFUTURE INVEST ApS has published its annual report for 2021. Gross profit came to DKK -65,800, and the net result was DKK -44,513.
About JS BIOFUTURE INVEST ApS
JS BIOFUTURE INVEST ApS is a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2007. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named ApS KBUS 17 NR. 6222. The management consists of Jørgen Schøller. The company is owned by Jørgen Schøller and Anna Carina Wiborg Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,598 and a net result of DKK 1,492,381 compared with DKK -8,609 the year before. Equity in the 2025 report amounted to DKK 1,706,887.